ASCO 2021: Few Patients with Ovarian Cancer Undergo Genetic Testing
Testing for mutations in BRCA1 and BRCA2 is recommended for all women with ovarian cancer, given important implications for treatment and prognosis. Despite this recommendation, studies show that only a small percentage of...
Read More